The Board of Directors at Owlstone Medical is responsible for overseeing the company's strategic direction, ensuring effective governance, and providing high-level guidance to achieve its mission of saving 100,000 lives and reducing $1.5 billion in healthcare costs through innovative breath biopsy technology. They provide executive oversight and make pivotal decisions to drive growth and sustain the company's leadership in non-invasive breath biomarker research.
View all